FGF21 and hypertriglyceridemia: However, mounting studies also support that plasma FGF21 levels are markedly increased in obesity, insulin-resistant, hypertriglyceridemia, hepatosteatosis and liver injury states [43, 44], suggesting that FGF21 did not exert its beneficial effects on lipid and glucose homeostasis.